Evaluation of the Prevalence of anomalIes of Glucose Metabolism in Patients Undergoing a Coronary Artery Bypass Graft (CABG)

Completed

• Conditions: Anomalies in Glucose Metabolism; Coronary Artery Bypass Graft

• Registration Number: NCT02855879
• Lead Sponsor: Centre Hospitalier Universitaire Dijon

Brief Summary

The aim of this study is to determine the prevalence of diabetes and non-diabetic glucose metabolism anomalies (glucose intolerance, non-diabetic fasting hyperglycaemia in patients about to undergo coronary artery bypass grafting (CABG).

In addition, the effect of these anomalies on post CABG morbi/mortality in the short term will be evaluated.

Detailed Description

Not available

Study Timeline

• Study Start: 2015-04-08
• Study First Submitted: 2016-07-28
• Study First Submitted QC: 2016-08-01
• Study First Posted: 2016-08-04
• Primary Completion: 2019-06-05
• Study Completion: 2019-06-05
• Status Verified: 2019-12
• Last Update Submitted: 2019-12-10
• Last Update Posted: 2019-12-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 286

Inclusion Criteria

• persons who have provided oral consent
• patients about to undergo coronary artery bypass grafting
• age >18 years

Exclusion Criteria

• persons without national health insurance cover
• Adults under guardianship
• Pregnant or breast-feeding women

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Percentage of glucose anomalies (non-diabetic fasting hyperglycaemia, glucose intolerance, diabetes) in CAD patients about to undergo coronary artery bypass grafting.	Change from inclusion to week 2 and up to month 3

Trial Locations

Locations (1)

CHU Dijon Bourgogne; 🇫🇷 Dijon, France